Literature DB >> 14970013

The high-field-strength curmudgeon.

Jeffrey S Ross.   

Abstract

Mesh：

Year:  2004        PMID： 14970013      PMCID： PMC7974604     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  5 in total

1.  Single-voxel proton MRS of the human brain at 1.5T and 3.0T.

Authors:  P B Barker; D O Hearshen; M D Boska
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

2.  Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison.

Authors:  O Gonen; S Gruber; B S Li; V Mlynárik; E Moser
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

3.  High-resolution intracranial and cervical MRA at 3.0T: technical considerations and initial experience.

Authors:  M A Bernstein; J Huston; C Lin; G F Gibbs; J P Felmlee
Journal:  Magn Reson Med       Date:  2001-11       Impact factor: 4.668

4.  High-resolution T2-reversed magnetic resonance imaging on a high magnetic field system. Technical note.

Authors:  Y Fujii; N Nakayama; T Nakada
Journal:  J Neurosurg       Date:  1998-09       Impact factor: 5.115

5.  Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging.

Authors:  Richard Frayne; Bradley G Goodyear; Peter Dickhoff; M Louis Lauzon; Robert J Sevick
Journal:  Invest Radiol       Date:  2003-07       Impact factor: 6.016
  5 in total
  13 in total

1.  High-resolution 3D-constructive interference in steady-state MR imaging and 3D time-of-flight MR angiography in neurovascular compression: a comparison between 3T and 1.5T.

Authors:  M Garcia; R Naraghi; T Zumbrunn; J Rösch; P Hastreiter; A Dörfler
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Advantages and pitfalls in 3T MR brain imaging: a pictorial review.

Authors:  Bernd L Schmitz; Andrik J Aschoff; Martin H K Hoffmann; Georg Grön
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

3.  Enhancing gray-to-white matter contrast in 3T T1 spin-echo brain scans by optimizing flip angle.

Authors:  Bernd L Schmitz; Georg Grön; Florian Brausewetter; Martin H K Hoffmann; Andrik J Aschoff
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

4.  3T MR imaging: the pros and cons.

Authors:  Pradip M Pattany
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

Review 5.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

6.  The time for 3T clinical imaging is now.

Authors:  Marc D Shapiro; Tom Magee; David Williams; Rick Ramnath; Jeffrey S Ross
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

Review 7.  Advances in magnetic resonance neuroimaging.

Authors:  Michael E Moseley; Chunlei Liu; Sandra Rodriguez; Thomas Brosnan
Journal:  Neurol Clin       Date:  2009-02       Impact factor: 3.806

8.  Detection of brain metastasis at 3T: comparison among SE, IR-FSE and 3D-GRE sequences.

Authors:  Shingo Kakeda; Yukunori Korogi; Yasuhiro Hiai; Norihiro Ohnari; Junji Moriya; Koji Kamada; Mai Hanamiya; Toru Sato; Mika Kitajima
Journal:  Eur Radiol       Date:  2007-02-22       Impact factor: 5.315

9.  MRI assessment of experimental gliomas using 17.6 T.

Authors:  Marc A Schwarz; Mirko Pham; Xavier Helluy; Arnd Doerfler; Tobias Engelhorn
Journal:  Neuroradiology       Date:  2013-03-10       Impact factor: 2.804

10.  Gray matter-white matter contrast on spin-echo T1-weighted images at 3 T and 1.5 T: a quantitative comparison study.

Authors:  Yasutaka Fushimi; Yukio Miki; Shin-Ichi Urayama; Tsutomu Okada; Nobuyuki Mori; Takashi Hanakawa; Hidenao Fukuyama; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-07-07       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.